Home Government Regeneron eye drug tabbed ‘breakthrough therapy’ by FDA

Regeneron eye drug tabbed ‘breakthrough therapy’ by FDA

SHARE

Federal officials have designated Regeneron’s Eylea drug a breakthrough therapy for diabetic patients with retinal damage.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email

Comments are closed.